selected publications
-
Hematopoietic fitness of JAK2V617F myeloproliferative neoplasms is linked to clinical outcome.
Blood advances.
2022
Academic Article
GET IT
Times cited: 2 -
Interferon-alpha for treating polycythemia vera yields improved myelofibrosis-free and overall survival.
Leukemia.
2021
Academic Article
GET IT
Times cited: 38 -
Comparison of qSOFA and SIRS for predicting adverse outcomes of patients with suspicion of sepsis outside the intensive care unit.
Critical care (London, England).
2017
Academic Article
GET IT
Times cited: 147